Objectives (Educational Content) :
1. Identify clinically useful data that can be obtained via digital therapeutic platforms. 2. Summarize the benefits of remote patient monitoring of symptoms and health behaviors. 3. Compare current strategies for inter-visit data collection with digital monitoring solutions.
Target Audience:
General pediatricians, family physicians, nurse practitioners, physician assistants, social workers, psychologists, and nurses.
Identified Gap:
Digital technology allowing self-monitoring of health conditions is becoming more readily available. Pediatricians need to understand the advantages and limitations of this technology in managing children and adolescents with chronic diseases.
Estimated Time to Complete the Educational Activity:
1 hour(s)
Expiration Date for CE/CME Credit:
01-17-2025
Method of Participation in the Learning Process:
The learner will view the presentation, successfully complete a post-test and complete an activity evaluation.
Evaluation Methods:
All learners must successfully complete a post-test, as well as an activity evaluation, to claim CE/CME credit.
Disclosure:
The speaker has returned the disclosure form, indicating that the following relevant financial or other relationship with the following commercial interest: Kevin Hommel, PhD The following CME Committee/Planning Committee member(s) has the following relevant financial relationships with ineligible companies to disclose: Merck Maria Victorio, MD All relationships have been mitigated.
Accreditation Statement:
Children’s Hospital Medical Center of Akron is accredited by the Ohio State Medical Association to provide continuing medical education for physicians.
CHMCA designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit TM. Physicians should only claim the credit commensurate with the extent of their participation in the activity.
Bibliography:
Cognitive Behavioral Therapy Plus Amitriptyline for Chronic Migraine in Childrens and Adolescents A Randomized Clinical Trial Scott w. Powers, PhD; Susmita M. Kashikar-Zuck, PhD; Janell R. Allen, MS, Susan L. LeCates, MSN; Shalonda K. Slater, Phd:P Marium Zafar, PsyD; Marielle A. Kabbouche, MD; Hope L. O’Obrien, MD; Chad E. Shenk, PhD; Joseph R. Rausch, PhD; Andrew D. Hershey, MD, PhD JAMA 2013:310(24): 2622-2630.doi:10.1001/jama.2013.282533
Trial of Amitriptyline, Topiramate, and Placebo for Pediatric Migraine Scott W. Powers, PhD., Christopher S. Coffey, Ph.D, Leigh A. Chamberlin, R.D., M.Ed., Dixie J. Eckund, RN, MSN, Elizabeth A. Klinger, MS, Jon W. Yankey, MS, Leslie L. Korbee, BS, Linda L. Porter, PhD, and Andrew D. Hershey, MD, PhD, for the CHAMP Investigators
